Group One Trading’s IGC Pharma IGC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-9,500
Closed -$2.66K 7449
2023
Q4
$2.66K Sell
9,500
-1,300
-12% -$403 ﹤0.01% 6733
2023
Q3
$3.88K Hold
10,800
﹤0.01% 6814
2023
Q2
$3.37K Buy
10,800
+400
+4% +$130 ﹤0.01% 6887
2023
Q1
$3.53K Buy
10,400
+6,000
+136% +$2.25K ﹤0.01% 6429
2022
Q4
$1.4K Sell
4,400
-5,400
-55% -$2.2K ﹤0.01% 6756
2022
Q3
$4K Buy
9,800
+900
+10% +$480 ﹤0.01% 6925
2022
Q2
$5K Sell
8,900
-600
-6% -$378 ﹤0.01% 7101
2022
Q1
$9K Sell
9,500
-12,800
-57% -$12.4K ﹤0.01% 7202
2021
Q4
$22K Sell
22,300
-32,200
-59% -$43.2K ﹤0.01% 6912
2021
Q3
$81K Buy
54,500
+20,700
+61% +$33.5K ﹤0.01% 6114
2021
Q2
$55K Buy
33,800
+8,200
+32% +$12.5K ﹤0.01% 6486
2021
Q1
$46K Buy
25,600
+12,600
+97% +$22.9K ﹤0.01% 6280
2020
Q4
$20K Buy
13,000
+4,800
+59% +$7.09K ﹤0.01% 5518
2020
Q3
$9K Buy
+8,200
New +$8.33K ﹤0.01% 5457
2020
Q2
Sell
-1,200
Closed -$1K 5957
2020
Q1
$1K Sell
1,200
-3,800
-76% -$2.11K ﹤0.01% 5077
2019
Q4
$3K Buy
+5,000
New +$4.09K ﹤0.01% 4839
2019
Q2
Sell
-300
Closed -$1K 5138
2019
Q1
$1K Buy
+300
New +$682 ﹤0.01% 4658

Other funds holding IGC

Group One Trading's IGC Position: Q1 2026 in Review

Group One Trading reduced its IGC Pharma (IGC) stake by 48% in Q1 2026, selling an estimated $950 and leaving 3,762 shares worth $989. The position accounts for ﹤0.01% of the portfolio, ranked #7215.

Group One Trading first reported a position in IGC in Q4 2019 and has held it in 24 quarters since. The position peaked at $99K in Q1 2021. 35 funds tracked by Wall St. Rank hold IGC as of Q1 2026.

  • Group One Trading held 3,762 shares of IGC Pharma worth $989 as of Q1 2026.
  • Group One Trading sold 3,425 IGC Pharma shares in Q1 2026, an estimated $950.
  • IGC Pharma made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #7215 holding.
  • Group One Trading first reported a position in IGC Pharma in Q4 2019 and has held it in 24 quarters since.
  • Group One Trading's IGC Pharma position peaked at $99K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held IGC Pharma as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.